New diabetes clinical trial: To Evaluate the Efficacy and Safety of Enavogliflozin in Patients With Type II Diabetes Mellitus Accompanied by Hypertension or Dyslipidemia

Published on: October 17, 2024 at 11:00PM
Conditions: Diabetes Mellitus, Type 2
Interventions: Drug: Enavogliflozin; Drug: Enavogliflozin
Sponsors: Daewoong Pharmaceutical Co. LTD.
Not yet recruiting
https://ift.tt/5cPGvkq